ArticleNutrition & diabetes2016

Treatment with FGFR2-IIIc monoclonal antibody suppresses weight gain and adiposity in KKA

K Nonogaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.